Overview
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 7, 2025 | Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution” | Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution” Fri, Mar 07, 2025 08:40 CET Report this content Antibiotic resistance is a growing global crisis, increasing the urgency for effective treatments. W... |
| Nov 9, 2024 | Venus Remedies and Apollo Hospitals: Pioneering Healthcare Expansion in India | In the ever-evolving landscape of healthcare, two companies are making significant strides: Venus Remedies and Apollo Hospitals. Both are not just expanding their footprints but are also reshaping the healthcare narrative in India. Their re... |
| Nov 5, 2024 | Venus Remedies secures Malaysian PIC/S Certification for pre-filled syringe facility | Venus Remedies Limited has received Good Manufacturing Practices (GMP) approval with PIC/S accreditation from Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) for its pre-filled syringe facility in Baddi, India. The certification... |
| Jul 15, 2021 | Venus Remedies Enters Consumer Healthcare Business With R3SET Launch | To introduce disruptive products overthe next fiveyears, covering key segments like pain management, gastro-enterology, hygiene, stress management, vitamins, and supplements Offers holistic pain management solution called R3SET, which ensur... |
| Feb 24, 2015 | Budget Expectation from Mr Pawan Chaudhary, CMD, Venus Remedies | India Quote of Mr Pawan Chaudhary, Chairman and Managing Director, Venus Remedies on his expectations from the 2015-16 Union Budget: The Union Finance Minister should take his government’s “Make in India” campaign to the next level by takin... |
| Feb 9, 2015 | Venus Remedies Bags Indian Patent for Vancoplus | Chandigarh, Punjab, India The novel antibiotic adjuvant entity is highly effective against drug-resistant infections, different resistance mechanisms which no other existing therapeutic options available in the market are able to tackle Van... |
| Nov 11, 2014 | Venus Strengthens Portfolio in Swiss Market with Marketing Authorisation for Meropenem | Chandigarh, Punjab, India Gets approval from Swiss drug authority Swissmedic through its German subsidiary Venus Pharma GmbH for meropenem 500 mg, 1 g injections With plans to launch the product early next year through its partner Swiss Pha... |
| Sep 25, 2014 | Venus Forays Into Singapore’s Topical Pain Management Market with Marketing Approval, Patent for Trois | Chandigarh, Punjab, India Company holding talks with various pharmaceutical firms for tie-ups Trois has a huge potential in Singapore, where 10% people are diagnosed with arthritis, 73.4% of the office workers suffer from musculoskeletal di... |
| Sep 8, 2014 | Venus Ties Up with Mylan for Marketing Meropenem in Three European Countries | Chandigarh, Punjab, India The distribution-cum-outlicensing agreement between Venus Pharma GmbH, Germany and Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for five years While the drug will be manufactu... |
Reviews 0
FAQ about Venus Remedies
When was Venus Remedies founded?
Venus Remedies was founded in 1989.
What has the press written about Venus Remedies?
Parsers VC has collected 12 articles mentioning Venus Remedies, among them “Medivir’s CEO to BioStock: “I am proud to see our research contribute to a global solution”” (Mar 7, 2025) and “Venus Remedies and Apollo Hospitals: Pioneering Healthcare Expansion in India” (Nov 9, 2024).
Is Venus Remedies still active?
Yes, Venus Remedies is active; its latest activity on Parsers VC dates from May 23, 2026.